On (b)(6) 2009, he underwent a right wright medical conserve plus resurfacing tha done by dr.(b)(6).The implant is a wright medical conserve plus resurfacing with 58 mm od and 52 mm id.He notes that he has always had some lateral right hip discomfort since surgery.In 2016, started developing significant peripheral neuropathy and new right hip groin pain, which became limiting.On (b)(6) 2017, his serum / plasma cobalt level was 1.3 ppb and his urine cobalt level was 17 ppb.He concurrently developed new problem with cognitive function including memory and confusion.He started experiencing new cardiomyopathy with new hypertension, new anemia, new diagnosis of sleep apnea, new night sweats, new tinnitus, new vision cloudiness, mood disorder, acute rash, headaches, and rest tremor.New angioedema and anaphylaxis to multiple medications.Metal suppression mri of the right hip showed adverse reaction to metallic debris involving a 2 cm intra-articular pseudotumor at the junction of the femoral resurfacing of the superior aspect of the femoral neck.On (b)(6) 2017, his right tha was revised to a zimmer ml t stem 11 ex, continuum 64 mm od shell with 3 dome screw, vivacity-e 36 mm id, delta ceramic head size 36 mm + 0.There was 10 cc effusion of the hip, which was collected and sent for cobalt and chromium levels.Cobalt level of the right hip fluid was 150 ppb and chromium was 170 ppb.There was friable synovitis with grey-brown areas.The acetabular component was well positioned and soundly ingrown.Frozen section report by pathology called into the room notable for some pmns but below criteria for infection with prominent lymphocytic and tissue necrosis c/w adverse reaction to metallic debris.Fda safety report id # (b)(4).
|